京都医療センター

臨床研究センター

内分泌代謝高血圧研究部

発表論文

2024年

  • Yamamoto Y, Ikeue K, Kanasaki M, Yamakage H, Oishi K, Mori T, Satoh-Asahara N, Masuda I, Ishii K. Association between subjective walking speed and metabolic diseases in individuals with obesity: a cross-sectional analysis. Scientific Reports, in press 2024
  • Ishihara Y, Kusakabe T, Yasoda A, Kitamura T, Nanba K, Tsuiki M, Satoh-Asahara N, Tagami T. Comparison of the utility of SARC-F, SARC-CalF, and calf circumference as screening tools for sarcopenia in patients with osteoporosis. PLOS ONE, 19(10):e0310401, 2024
  • Ishii K, Ogawa W, Kimura Y, Kusakabe T, Miyazaki R, Sanada K, Satoh-Asahara N, Someya Y, Tamura Y, Ueki K, Wakabayashi H, Watanabe Y, Yamada M, Arai H. Diagnosis of Sarcopenic Obesity in Japan: Consensus Statement of the Japanese Working Group on Sarcopenic Obesity. Geriatrics & Gerontology International, 24(10):997-1000, 2024
  • Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K, Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M, Murata T & The ISCHIA Study Group. Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study. Diabetology International, 2024
  • Kishimoto A, Komiyama M, Wada H, Satoh-Asahara N, Yamakage H, Ajiro Y, Aoyama H, Katsuura Y, Imaizumi A, Hashimoto T, Sunagawa Y, Morimoto T, Kanai M, Kakeya H, Hasegawa K. Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial. Journal of Health, Population and Nutrition, 43, 93, 2024
  • Bouchi R, Izumi K, Ishizuka N, Uemura Y, Ohtsu H, Miyo K, Tanaka S, Satoh-Asahara N, Hara K, Odawara M, Kusunoki Y, Koyama H, Onoue T, Arima H, Tsushita K, Watada H, Kadowaki T, Ueki K. Internet of things-based approach for glycemic control in people with type 2 diabetes: a randomized controlled trial. Journal of Diabetes Investigation, Online ahead of print, 2024
  • Kusakabe T, Ishihara Y, Kitamura T, Yasoda A, Nanba K, Tsuiki M, Satoh-Asahara N, Tagami T. Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta. Osteoporosis International, Online ahead of print, 2024
  • Yamakage H, Jo T, Tanaka M, Kato S, Hasegawa K Masuda I, Matsuhisa M, Kotani K, Noda M, Satoh-Asahara N. Five percent weight loss is a significant 1-year predictor and an optimal 5-year cut-off for reducing the number of obesity-related cardiovascular disease risk components: the Japan Obesity and Metabolic Syndrome Study. Frontiers in Endocrinology, Provisionally accepted, 2024
  • Mittal S, Komiyama M, Yamakage H, Satoh-Asahara N, Yasoda A, Wada H, Funamoto M, Shimizu K, Katanasaka Y, Sunagawa Y, Morimoto Y, Takahashi Y, Nakayama T, Hasegawa K. Atherogenic biomarkers and gingival bleeding among smokers. E Journal of Cardiovascular Medicine, 12(1), 2024
  • Yamamoto Y, Ikeue K, Kanasaki M, Yamakage H, Satoh-Asahara N, Masuda I, Ishii K. Age-wise examination of the association of obesity based on body mass index and waist circumference with metabolic diseases in comprehensive health checkup participants. Obesity Science & Practice, 10, e746, 2024.
  • Nanba K, Blinder A, Udager A, Hirokawa Y, Miura T, Okuno H, Moriyoshi K, Yamazaki Y, Sasano H, Yasoda A, Satoh-Asahara N, Rainey W, Tagami T. Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma. Frontiers in Endocrinology, 15, 2024.
  • Manaka K, Kato S, Sakamoto R, Yamakage H, Uema T, Kawai S, Shibata M, Hiratsuka I, I Nakachi S, Onoue T, Tsuchiya T, Fukui M, Hashimoto K, Suzuki A, Makita N, Ogawa Y, Arima H, Satoh-Asahara N, Masuzaki H, Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society. Endocline Journal, in press 2024.
  • Kato H, Iwashita K, Iwasa M, Kato S, Yamakage H, Suganami T, Tanaka M, Satoh-Asahara N. Imeglimin Exhibits Novel Anti-Inflammatory Effects on High-Glucose-Stimulated Mouse Microglia through ULK1-Mediated Suppression of the TXNIP–NLRP3 Axis. Cells, 13(3), 284, 2024
  • Mittal S, Komiyama M, Ozaki Y, Yamakage H, Satoh-Asahara N, Wada H, Yasoda A, Funamoto M, Katanasaka Y, Sunagawa Y, Morimoto T, Akao M, Abe M, Takahashi Y, Nakayama T, Hasegawa K, Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. European Heart Journal Open, 4(1), 2024